These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36935026)
1. Neoadjuvant Simultaneous Integrated Boost Radiation Therapy Improves Clinical Outcomes for Retroperitoneal Sarcoma. Liveringhouse CL; Palm RF; Bryant JM; Yang GQ; Mills MN; Figura ND; Ahmed KA; Mullinax J; Gonzalez R; Johnstone PA; Naghavi AO Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):123-138. PubMed ID: 36935026 [TBL] [Abstract][Full Text] [Related]
2. Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial. Smith MJ; Ridgway PF; Catton CN; Cannell AJ; O'Sullivan B; Mikula LA; Jones JJ; Swallow CJ Radiother Oncol; 2014 Jan; 110(1):165-71. PubMed ID: 24411227 [TBL] [Abstract][Full Text] [Related]
3. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience. Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884 [TBL] [Abstract][Full Text] [Related]
4. Radiation therapy for retroperitoneal sarcoma: practice patterns in North America. Ruff SM; Heh V; Konieczkowski DJ; Onuma A; Dunlop HM; Kim AC; Grignol VP; Contreras CM; Pawlik TM; Pollock R; Beane JD Radiat Oncol; 2024 Mar; 19(1):38. PubMed ID: 38491404 [TBL] [Abstract][Full Text] [Related]
5. The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas. Nussbaum DP; Speicher PJ; Gulack BC; Ganapathi AM; Keenan JE; Stinnett SS; Kirsch DG; Tyler DS; Blazer DG Surg Oncol; 2014 Sep; 23(3):155-60. PubMed ID: 25085344 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors. Youssef E; Fontanesi J; Mott M; Kraut M; Lucas D; Mekhael H; Ben-Josef E Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):514-9. PubMed ID: 12243830 [TBL] [Abstract][Full Text] [Related]
7. Factors associated with disease-free and abdominal recurrence-free survival in abdominopelvic and retroperitoneal sarcomas. Bredbeck BC; Delaney LD; Kathawate VG; Harter CA; Wilkowski J; Chugh R; Cuneo KC; Dossett LA; Sabel MS; Angeles CV J Surg Oncol; 2022 Jun; 125(8):1292-1300. PubMed ID: 35239187 [TBL] [Abstract][Full Text] [Related]
8. Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. McBride SM; Raut CP; Lapidus M; Devlin PM; Marcus KJ; Bertagnolli M; George S; Baldini EH Ann Surg Oncol; 2013 Jul; 20(7):2140-7. PubMed ID: 23392853 [TBL] [Abstract][Full Text] [Related]
9. Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients. Bishop AJ; Zagars GK; Torres KE; Hunt KK; Cormier JN; Feig BW; Guadagnolo BA Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):158-65. PubMed ID: 26130233 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis. Li X; Dong R; Xiao M; Min L; Luo C Radiat Oncol; 2022 Dec; 17(1):215. PubMed ID: 36578082 [TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal soft tissue sarcoma: low-dose neoadjuvant radiation therapy followed by surgery with or without intraoperative radiotherapy and adjuvant radiation therapy. Kirste S; Landenberger N; Scholber J; Henne K; Wittel UA; Grosu AL Strahlenther Onkol; 2019 Jun; 195(6):558-565. PubMed ID: 30972454 [TBL] [Abstract][Full Text] [Related]
13. Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. Chouliaras K; Senehi R; Ethun CG; Poultsides G; Grignol V; Clarke CN; Roggin KK; Fields RC; Schwartz PB; Ronnekleiv-Kelly SM; D'Agostino R; Johnson EN; Levine EA; Cardona K; Votanopoulos KI J Surg Oncol; 2019 Dec; 120(7):1227-1234. PubMed ID: 31486096 [TBL] [Abstract][Full Text] [Related]
14. The Benefit of Adjuvant Radiotherapy in High-grade Nonmetastatic Retroperitoneal Soft Tissue Sarcoma: A SEER Analysis. Bates JE; Dhakal S; Mazloom A; Constine LS Am J Clin Oncol; 2018 Mar; 41(3):274-279. PubMed ID: 26703813 [TBL] [Abstract][Full Text] [Related]
18. Perioperative radiotherapy versus surgery alone for retroperitoneal sarcomas: a systematic review and meta-analysis. Diamantis A; Baloyiannis I; Magouliotis DE; Tolia M; Symeonidis D; Bompou E; Polymeneas G; Tepetes K Radiol Oncol; 2020 Feb; 54(1):14-21. PubMed ID: 32114526 [TBL] [Abstract][Full Text] [Related]
19. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas. Stahl JM; Corso CD; Park HS; An Y; Rutter CE; Han D; Roberts KB Eur J Surg Oncol; 2017 Jan; 43(1):168-174. PubMed ID: 27335080 [TBL] [Abstract][Full Text] [Related]
20. Use of tissue expanders and pre-operative external beam radiotherapy in the treatment of retroperitoneal sarcoma. White JS; Biberdorf D; DiFrancesco LM; Kurien E; Temple W Ann Surg Oncol; 2007 Feb; 14(2):583-90. PubMed ID: 17094026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]